Erythrocyte pyrimidine 5'-nucleotidase and deoxynucleotidase isozymes: metallosensitivity and kinetics - PubMed

Erythrocyte pyrimidine 5'-nucleotidase and deoxynucleotidase isozymes: metallosensitivity and kinetics

L Cook et al. Drug Chem Toxicol. 1988 Jun.

Abstract

Erythrocytes from a subject with classical pyrimidine 5'-nucleotidase (P5N) deficiency (PND) possessed typically low nucleotidase activity with uridine 5'-monophosphate (UMP) and cytidine 5'-monophosphate (CMP) as the substrates with subnormal dephosphorylation of 2'-deoxy thymidine 5'-monophosphate (dTMP) and 2'-deoxyuridine 5'-monophosphate (dUMP) and intermediate activity with 2'-deoxycytidine 5'-monophosphate (dCMP). Contrary to previously reported data, there was enzyme activity with all five substrates. The metallosensitivities of the P5N isozymes using UMP, dUMP, dCMP and dTMP as the substrates were defined. Nucleotidase (P5N) is slightly more sensitive than 2'-deoxy-pyrimidine 5'-nucleotidase (dP5N) to inhibition by lead, copper and mercury. Chromium stimulated more enzyme activity with dCMP than other substrates. Apparent Michaelis constants (Km) were calculated for UMP, CMP, dUMP, dCMP, and dTMP for PND and control subjects. Optimal activity was at pH 7.0-7.8 when using UMP and CMP as the substrates but at pH 5.5-6.5 with dUMP, dCMP and dTMP as the substrates. The Km, pH optima and metallosensitivities were, however, consistent with electrophoretic evidence for two and probably three isozymes: P5N with maximal affinity for UMP and CMP; dP5N with maximal affinity for dUMP and dTMP; and a closely related dCMPase. The relative activity with representative substrates can be used to distinguish homozygotes and heterozygotes for P5N deficiency and subjects with heavy metal exposure.

Similar articles

• Isozymes of human erythrocyte pyrimidine 5'-nucleotidase--chromatographic separation and their properties.

  Hirono A, Fujii H, Miwa S. Hirono A, et al. Jpn J Exp Med. 1985 Feb;55(1):37-44. Jpn J Exp Med. 1985. PMID: 2993713

• Erythrocyte arginase, pyrimidine 5'-nucleotidase (P5N), and deoxypyrimidine 5'-nucleotidase (dP5N) as indices of lead exposure.

  Cook LR, Angle CR, Stohs SJ. Cook LR, et al. Br J Ind Med. 1986 Jun;43(6):387-90. doi: 10.1136/oem.43.6.387. Br J Ind Med. 1986. PMID: 3013277 Free PMC article.

• Analysis of human erythrocyte 5'-nucleotidases in healthy individuals and a patient deficient in pyrimidine 5'-nucleotidase.

  Swallow DM, Aziz I, Hopkinson DA, Miwa S. Swallow DM, et al. Ann Hum Genet. 1983 Jan;47(1):19-23. doi: 10.1111/j.1469-1809.1983.tb00966.x. Ann Hum Genet. 1983. PMID: 6301356

• Isozymes of human erythrocyte pyrimidine 5'-nucleotidase.

  Oda T, Nagao M, Shirono K, Kagimoto T, Takatsuki K. Oda T, et al. J Lab Clin Med. 1985 Dec;106(6):646-50. J Lab Clin Med. 1985. PMID: 2999273

• The enzymology of cytosolic pyrimidine 5'-nucleotidases: functional analysis and physiopathological implications.

  Magni G, Amici A, Orsomando G. Magni G, et al. Curr Med Chem. 2013;20(34):4304-16. doi: 10.2174/0929867311320340009. Curr Med Chem. 2013. PMID: 23992312 Review.

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon

• Other Literature Sources

  • The Lens - Patent Citations Database

• Research Materials

  • NCI CPTC Antibody Characterization Program